» Articles » PMID: 20698949

Anti-HCV Reactive Volunteer Blood Donors Distribution Character and Genotypes Switch in Xi'an, China

Overview
Journal Virol J
Publisher Biomed Central
Specialty Microbiology
Date 2010 Aug 12
PMID 20698949
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

HCV is prevailed in the world as well as in China. Blood transfusion is one of the most common transmission pathways of this pathogen. Although data of HCV infection character were reported during the past years, anti-HCV reactive profile of China donors was not fully clear yet. Furthermore, infection progress was found related to the HCV genotype. Different genotype led to different efficacy when interferon was introduced into HCV therapy. Here we provided character data of HCV infection in China blood donors from the year of 2000 to 2009. The infection rate in local donors was lower than general population and descended from 0.80% to 0.40% or so in recent years. About 83% HCV strains were categorized into genotypes 1b and 2a. But 1b subtype cases climbed and 2a subtype cases decreased. The current study threw more light on HCV infection of blood donors in China, at least in the Northern region.

Citing Articles

Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution.

Zhang Y, Chen L, He M Virol J. 2017; 14(1):41.

PMID: 28231805 PMC: 5324300. DOI: 10.1186/s12985-017-0710-z.


Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004-2007 and 2008-2011.

Rong X, Xu R, Xiong H, Wang M, Huang K, Chen Q Arch Virol. 2014; 159(12):3231-7.

PMID: 25085624 PMC: 4221604. DOI: 10.1007/s00705-014-2185-1.


Characterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina Faso.

Zeba M, Sanou M, Bisseye C, Kiba A, Nagalo B, Djigma F Blood Transfus. 2014; 12 Suppl 1:s54-7.

PMID: 24599906 PMC: 3934227. DOI: 10.2450/2013.0089-12.


Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china.

Yan Z, Fan K, Wang Y, Fan Y, Tan Z, Deng G Hepat Mon. 2012; 12(3):196-204.

PMID: 22550528 PMC: 3339420. DOI: 10.5812/hepatmon.857.

References
1.
Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B . Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol. 1999; 143(12):2493-503. DOI: 10.1007/s007050050479. View

2.
Simmonds P . Genetic diversity and evolution of hepatitis C virus--15 years on. J Gen Virol. 2004; 85(Pt 11):3173-3188. DOI: 10.1099/vir.0.80401-0. View

3.
Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M . Randomized trial of prolonged interferon retreatment for chronic hepatitis C patients with HCV-genotype 1b and high virus load. Hepatol Res. 2003; 25(4):364-370. DOI: 10.1016/s1386-6346(02)00327-3. View

4.
Liu L, Zhang R, Li J, Du S, Jin D, Wei L . [The distribution of hepatitis C virus genotype 1a in Yanbian area]. Zhonghua Yi Xue Za Zhi. 2007; 87(20):1407-10. View

5.
Fu Y, Xia W, Wang Y, Tian L, Pybus O, Lu L . The seroprevalence of hepatitis C virus (HCV) among 559,890 first-time volunteer blood donors in China reflects regional heterogeneity in HCV prevalence and changes in blood donor recruitment models. Transfusion. 2010; 50(7):1505-11. PMC: 3743680. DOI: 10.1111/j.1537-2995.2010.02616.x. View